SCHEMBL15917454

SCHEMBL15917454

COc1ccc2c(C)c(Cc3ccccc3)c(=O)oc2c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.74
ALDH1A2 O94788 1/20 0.74
ALDH1B1 P30837 1/20 0.74
ALDH1A3 P47895 1/20 0.74
STS P08842 1/20 0.73
SMN1; SMN2 Q16637 5/20 0.72
HPGD P15428 4/20 0.72
LMNA P02545 2/20 0.72
KDM4E B2RXH2 9/20 0.71
KMT2A Q03164 3/20 0.71
GAA P10253 2/20 0.71
MEN1 O00255 2/20 0.70
NPSR1 Q6W5P4 2/20 0.69
GLA P06280 1/20 0.69
HSD17B3 P37058 1/20 0.69
ERAP1 Q9NZ08 1/20 0.69
MAP2K1 Q02750 1/20 0.67
ACLY P53396 1/20 0.64
MAPT P10636 1/20 0.64
THRB P10828 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24627780 0.89 MAPT (0.72) ALDH1A1ALDH1A2ALDH1B1ALDH1A3STS
SCHEMBL29527739 0.87 ALDH1A1 (0.88) ALDH1A1ALDH1A2ALDH1B1ALDH1A3STS
SCHEMBL970190 0.86 MAP2K1 (0.70) ALDH1A1ALDH1A2ALDH1B1ALDH1A3STS
SCHEMBL972176 0.84 ALDH1A1 (0.78) ALDH1A1ALDH1A2ALDH1B1ALDH1A3STS
SCHEMBL26434307 0.84 ALDH1A1 (0.84) ALDH1A1ALDH1A2ALDH1B1ALDH1A3STS
SCHEMBL14317937 0.83 ALDH1A1 (0.60) ALDH1A1ALDH1A2ALDH1B1ALDH1A3STS
SCHEMBL2247578 0.83 MAP2K1 (0.81) ALDH1A1ALDH1A2ALDH1B1ALDH1A3STS
SCHEMBL29527472 0.82 ALDH1A1 (0.68) ALDH1A1ALDH1A2ALDH1B1ALDH1A3STS
SCHEMBL971942 0.82 KDM4E (1.00) ALDH1A1ALDH1A2ALDH1B1ALDH1A3STS
SCHEMBL12204222 0.81 KDM4E (0.70) ALDH1A1ALDH1A2ALDH1B1ALDH1A3STS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9334256-B2 Agents and methods for treating ischemic and other diseases NONO INC. (CA) 2016-05-10 US disclosed
US-20140221423-A1 Agents And Methods For Treating Ischemic And Other Diseases NONO INC. (CA) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221423-A1 Agents And Methods For Treating Ischemic And Other Diseases TRPM7, TRPM8, TRPM5 ALDH1A1 1722/4885ALDH1A2 95/4885ALDH1B1 915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.